Goldring Centre for High Performance Sport
Toronto, Ontario, M5S2C9, Canada
NCT Number: NCT03319147
The primary objective is to determine the impact of essential amino acids on integrated muscle protein synthesis over 4 days after resistance exercise.
In addition, the secondary objective is to determine the effect of essential amino acids on satellite cell regulation and inflammatory responses during this prolonged recovery period.
Looking for future studies?
Notify Me18 year–35 year
Male
Interventional
Not applicable
Toronto, Ontario, M5S2C9, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
4g of essential amino acids
4g of maltdextrin
Time frame: 4 hours
Skeletal muscle fractional synthesis rate (%/h) will be determined by oral pulse method using ring-[D5]phenylalanine
Time frame: 4 days
Maximal strength (torque in n-M) of the knee extensors will be assessed by a maximal isometric voluntary contraction (MVC).
Time frame: 4 days
Corresponding subjective ratings of muscle soreness will be collected from participants using a visual analogue scale (mm)
Time frame: 4 days
Muscle damage will be determined by histochemical analysis. muscle damage is defined as Z-band streaming.
University of Toronto
Other
Effect of Leucine-enriched Essential Amino Acid on Integrated Muscle Protein Synthesis and Muscle Recovery After Resistance Exercise
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06967714
Behavior, Healthy
Brussels, Belgium
View Trial DetailsNCT07276464
Behavior, Colitis
Bruz, Britanny, France
View Trial DetailsNCT03886558
Aging, Behavior
Pontevedra, Spain
View Trial DetailsNCT03876314
Alzheimer Disease, Behavior
Greensboro, North Carolina, United States
View Trial Details